Market Cap
$17.4B
MEDP
Medpace Holdings, Inc.
$608.79 ▲ +1.79%
Prev close $598.08Market cap$17.4B
ConsensusSell
12-mo target$589.92 (-3.1%)
▼ Bearish
Analyst conviction 4/10
Insider Selling Cluster (5 insiders)21 New Institutional Positions29 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on MEDP right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Hold (35%)
Inst. Holders
50 funds
Inst. Value
$8.8B
Inst. Activity
21 buys / 29 sells
Insider Activity
$0.00 buy / $215.8M sell
Insider Net $
-$215.8M
SEC Reports
15
Congressional
4 trades
Price chart 30d +2.7%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 Insider
Troendle August J. sold 21,966 shares
President & CEO @ $625.47 ($13.7M)
Sep 29, 2026 Insider
Troendle August J. sold 26,701 shares
President & CEO @ $621.02 ($16.6M)
Sep 28, 2026 Insider
Troendle August J. sold 2,410 shares
President & CEO @ $620.07 ($1.5M)
Sep 7, 2026 dark_pool
Sep 1, 2026 SEC Dark Pool: MEDP — 0.2M shares, 19,271 trades
Week starting 2026-09-07. Total ATS volume: 221,175 shares across 19,271 trades.
Three Medpace insiders (CEO, CFO, Director) sold a combined $4.91M in open-market sales over a 7-day window. However, th
CLUSTER — Impact 2/10
A significant insider selling cluster at Medpace (MEDP) totaling $14.45M over a 7-day window, led by CEO August Troendle
CLUSTER — Impact 4/10
Four Medpace insiders, including the CEO, CFO, and two directors, sold a total of $10.0M in shares over a one-week windo
CLUSTER — Impact 3/10
Jun 30, 2026 Inst.
Mawer Investment Management Ltd. — TRIM
267,175 shares ($141.5M)
Analyst ratings buy % +483.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
35% rate it Buy or better · 20 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 30, 2026 | UBS | UPGRADE | Neutral | 55% |
| Jul 24, 2026 | Mizuho | MAINTAIN | Outperform | 52% |
| Jul 24, 2026 | BMO Capital | MAINTAIN | Market Perform | 53% |
| Jul 24, 2026 | Truist Securities | MAINTAIN | Hold | 55% |
| Jul 24, 2026 | TD Cowen | MAINTAIN | Hold | 56% |
| Jul 24, 2026 | RBC Capital | MAINTAIN | Outperform | 55% |
| Jul 24, 2026 | Baird | MAINTAIN | Neutral | 54% |
| Jul 13, 2026 | Mizuho | MAINTAIN | Outperform | 52% |
| Jul 8, 2026 | Baird | DOWNGRADE | Neutral | 54% |
| Jul 7, 2026 | Jefferies | DOWNGRADE | Hold | 53% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 5 | 12 | 1 | 0 | 35% | |
| Aug 1, 2026 | 2 | 5 | 12 | 1 | 0 | 35% | |
| Jul 1, 2026 | 4 | 5 | 10 | 1 | 0 | 45% | |
| Jun 1, 2026 | 4 | 5 | 10 | 1 | 0 | 45% | |
| May 1, 2026 | 4 | 5 | 10 | 1 | 0 | 45% | |
| Apr 1, 2026 | 4 | 5 | 10 | 1 | 0 | 45% | |
| Mar 1, 2026 | 4 | 4 | 9 | 2 | 0 | 42% | |
| Feb 1, 2026 | 0 | 1 | 11 | 4 | 2 | 6% |
Price targets
Where 13 covering analysts think MEDP trades over the next 12 months.
$589.92 -3.1% upside Hold
Current$608.79 Low$370.00 Median$609.00 High$692.00 13 analysts
$370.00$692.00
Analyst rating Hold· 2.9/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
15 SEC filing reports analyzed · 1 bullish, 2 bearish, 1 mixed, 11 neutral · avg impact 3.7/10.
NEUTRALCLUSTER2/10
Three Medpace insiders (CEO, CFO, Director) sold a combined $4.91M in open-market sales over a 7-day
Sep 1, 2026
NEUTRALCLUSTER4/10
A significant insider selling cluster at Medpace (MEDP) totaling $14.45M over a 7-day window, led by
Aug 29, 2026
NEUTRALCLUSTER3/10
Four Medpace insiders, including the CEO, CFO, and two directors, sold a total of $10.0M in shares o
Aug 28, 2026
BEARISHCLUSTER5/10
A cluster of insider selling at Medpace (MEDP) over the past week saw the CEO, CFO, and two director
Aug 26, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 28, 2026
Clinical Trial
Study to Assess the Efficacy and Safety of LIB003 in HeFH Patients on Oral Lipid Therapy Needing Further LDL-C Reduction
Phase Phase 3 — COMPLETED
Sep 8, 2026
Clinical Trial
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study
Phase Phase 3 — TERMINATED
Sep 7, 2026
dark_pool
Dark Pool: MEDP — 0.2M shares, 19,271 trades
Week starting 2026-09-07. Total ATS volume: 221,175 shares across 19,271 trades.
Aug 31, 2026
dark_pool
Dark Pool: MEDP — 0.3M shares, 24,893 trades
Week starting 2026-08-31. Total ATS volume: 271,518 shares across 24,893 trades.
Aug 24, 2026
dark_pool
Dark Pool: MEDP — 0.3M shares, 19,765 trades
Week starting 2026-08-24. Total ATS volume: 276,155 shares across 19,765 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $4.44 | $4.31–$4.69 | 15.0% | +0.0% | 6↑ 1↓ | $0.7B | 8 |
| Next Q | $4.70 | $4.48–$4.87 | 0.6% | +0.0% | 4↑ 2↓ | $0.7B | 8 |
| Current FY | $17.70 | $17.49–$18.37 | 15.9% | +0.0% | 9↑ 0↓ | $2.9B | 10 |
| Next FY | $19.31 | $17.60–$20.16 | 9.1% | +0.0% | 9↑ 1↓ | $3.0B | 10 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $4.438 | — |
| 7d ago | $4.438 | — |
| 30d ago | $4.438 | — |
| 60d ago | $4.303 | +0.135 |
| 90d ago | $4.284 | +0.155 |
Institutional ownership
Which big funds own MEDP (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $8.8B total value (16,663,065 shares) as of 2026-Q2. Top holders: BlackRock,, AQR, VANGUARD. Net selling activity: 29 institutions trimmed/exited vs 21 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 2,498,248 | $1.3B | 15.0% | — |
| AQR CAPITAL MANAGEMENT LLC | 1,278,935 | $677.3M | 7.7% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,133,357 | $600.2M | 6.8% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,026,820 | $543.8M | 6.2% | — |
| STATE STREET CORP | 710,895 | $376.5M | 4.3% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 710,465 | $376.3M | 4.3% | — |
| WASATCH ADVISORS LP | 636,595 | $337.1M | 3.8% | — |
| Invesco Ltd. | 579,241 | $306.8M | 3.5% | — |
| BAILLIE GIFFORD & CO | 473,211 | $250.6M | 2.8% | — |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 429,012 | $227.2M | 2.6% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Mawer Investment Management Ltd. | TRIM | 446,104 | 267,175 | -40.1% | $141.5M |
| Epoch Investment Partners, Inc. | ADD | 140,959 | 266,547 | +89.1% | $141.2M |
| TD ASSET MANAGEMENT INC | ADD | 133,053 | 263,872 | +98.3% | $139.7M |
| GOLDMAN SACHS GROUP INC | ADD | 168,487 | 250,781 | +48.8% | $132.8M |
| D. E. Shaw & Co., Inc. | TRIM | 432,602 | 234,537 | -45.8% | $124.2M |
| FULLER & THALER ASSET MANAGEMENT, INC. | DOUBLED | 73,655 | 230,555 | +213.0% | $122.1M |
| NORGES BANK | NEW | — | 226,954 | — | $120.2M |
| Clearbridge Investments, LLC | ADD | 175,966 | 226,104 | +28.5% | $119.7M |
| JPMORGAN CHASE & CO | ADD | 153,606 | 214,912 | +39.9% | $115.5M |
| AMERIPRISE FINANCIAL INC | ADD | 102,418 | 170,034 | +66.0% | $90.1M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
10 insiders, 50 transactions. Net -$215.8M — $0.00 bought, $215.8M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Troendle August J. | President & CEO | SELL | 21,966 | $625.47 | $13.7M |
| Sep 29, 2026 | Troendle August J. | President & CEO | SELL | 26,701 | $621.02 | $16.6M |
| Sep 28, 2026 | Troendle August J. | President & CEO | SELL | 2,410 | $620.07 | $1.5M |
| Sep 25, 2026 | Troendle August J. | President & CEO | SELL | 154 | $620.60 | $95.6K |
| Sep 24, 2026 | Troendle August J. | President & CEO | SELL | 27,833 | $621.33 | $17.3M |
| Sep 23, 2026 | Troendle August J. | President & CEO | SELL | 16,083 | $628.64 | $10.1M |
| Sep 22, 2026 | Troendle August J. | President & CEO | SELL | 49,018 | $628.11 | $30.8M |
| Sep 21, 2026 | Troendle August J. | President & CEO | SELL | 21,883 | $623.29 | $13.6M |
| Sep 17, 2026 | Troendle August J. | President & CEO | SELL | 10,880 | $620.40 | $6.7M |
| Sep 16, 2026 | Troendle August J. | President & CEO | SELL | 8,770 | $621.29 | $5.4M |
Congressional trades
MEDP trades disclosed by members of Congress, with disclosure delay.
2 members · 3 buys / 1 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | Medpace Holdings Inc | May 29, 2026(15d) |
| May 15, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | Medpace Holdings Inc | May 29, 2026(15d) |
| Feb 26, 2026 | David Taylor | R | HOUSE | BUY | $1,001 - $15,000 | Medpace Holdings Inc | Mar 9, 2026(12d) |
| Jan 15, 2026 | Gilbert Cisneros | D | HOUSE | SELL | $15,001 - $50,000 | Medpace Holdings Inc | Feb 16, 2026(33d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for MEDP.
Shares short
1,685,597
Settlement Sep 15, 2026
Change vs prior
+0.9%
Semi-monthly cycle
Days to cover
8.8
At avg daily volume
Of shares outstanding
≈6.0%
Estimate — not % of float
All MEDP filing & press-release reports (15)
- CLUSTER reportSep 1, 2026
- CLUSTER reportAug 29, 2026
- CLUSTER reportAug 28, 2026
- CLUSTER reportAug 26, 2026
- CLUSTER reportAug 25, 2026
- CLUSTER reportAug 22, 2026
- 144 reportAug 19, 2026
- CLUSTER reportAug 15, 2026
- CLUSTER reportAug 14, 2026
- CLUSTER reportAug 13, 2026
- CLUSTER reportJul 30, 2026
- 144 reportJul 27, 2026
- COURT-RULING reportJun 8, 2026
- 8-K reportApr 22, 2026
- DEFA14A reportApr 1, 2026